CRV — Craven House Capital Share Price
Last trade - 00:00- $0.68m
- $0.65m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 676.13 | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -205.25% | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st May | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.45 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Craven House Capital Plc is a United Kingdom-based investment company. The Company’s investing policy is primarily to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets participating in the e-commerce sector. Its investment portfolio comprises Garimon Limited, Stormfjord Limited, BioVitos Medical Limited, Rosedog Limited, and Honeydog Limited. Garimon Limited’s assets comprise ownership of the domain www.magazinos.com, a platform for digital magazine distribution. BioVitos Medical Limited has a license to market a patented heart drug, Succifer. Rosedog Limited is the owner of TV Zinos (www.tvzinos.com), a Website which offers a number of free-to-view television channels. The Company’s investment manager is Desmond Holdings Ltd.
Directors
- Last Annual
- May 31st, 2024
- Last Interim
- November 30th, 2024
- Incorporated
- May 10th, 2004
- Public Since
- August 4th, 2004
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
- London Stock Exchange
- Shares in Issue
- 3,863,590
- Address
- Craven HSE Capital, 776-778 Barking Road, LONDON, E13 9PJ
- Web
- http://www.cravenhousecapital.com/
- Phone
- +44 2032868130
- Auditors
- Edwards Veeder LLP
Latest News for CRV
Upcoming Events for CRV
Similar to CRV
3i
London Stock Exchange
450
London Stock Exchange
Aberdeen
London Stock Exchange
Achilles Investment Co
London Stock Exchange
Agronomics
London Stock Exchange
FAQ
As of Today at 20:05 UTC, shares in Craven House Capital are trading at $0.18. This share price information is delayed by 15 minutes.
Shares in Craven House Capital last closed at $0.18 and the price had moved by -12.5% over the past 365 days. In terms of relative price strength the Craven House Capital share price has underperformed the FTSE All Share Index by -14.9% over the past year.
There is no consensus recommendation for this security.
Find out moreCraven House Capital does not currently pay a dividend.
Craven House Capital does not currently pay a dividend.
Craven House Capital does not currently pay a dividend.
To buy shares in Craven House Capital you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.18, shares in Craven House Capital had a market capitalisation of $0.68m.
Here are the trading details for Craven House Capital:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: CRV
Based on an overall assessment of its quality, value and momentum Craven House Capital is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Craven House Capital. Over the past six months, its share price has underperformed the FTSE All Share Index by -12.92%.
As of the last closing price of $0.18, shares in Craven House Capital were trading -23.36% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Craven House Capital PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.18.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Craven House Capital's management team is headed by:
- Tamra Spink - SEC
- Balbir Bindra - DRC
- Calum Morrison - DRC
- Mark Pajak - NED